Integrating microRNA and mRNA expression profiles of acute promyelocytic leukemia cells to explore the occurrence mechanisms of differentiation syndrome Number of patients treated with a reduced dose of ATO or whose ATO treatment was discontinued 3 3
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Abbreviations: APL, acute promyelocytic leukemia; DS, differentiation syndrome; WBC, white blood cell; DIC, disseminated intravascular coagulation; ECOG, Eastern Cooperative Oncology Group; FAB, French-American-British; ATO, arsenic trioxide; DA, daunorubicin and cytarabine.
